Business Description
Opthea Ltd
NAICS : 325412
SIC : 2834
ISIN : AU000000OPT2
Description
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.22 | |||||
| Equity-to-Asset | -0.4 | |||||
| Debt-to-Equity | -1.87 | |||||
| Debt-to-EBITDA | -0.71 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -5.66 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -38.2 | |||||
| 3-Year EPS without NRI Growth Rate | -48.7 | |||||
| 3-Year FCF Growth Rate | -33.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 1962.65 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.39 | |||||
| 9-Day RSI | 53.84 | |||||
| 14-Day RSI | 49.13 | |||||
| 6-1 Month Momentum % | 79.18 | |||||
| 12-1 Month Momentum % | 128.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.94 | |||||
| Quick Ratio | 2.94 | |||||
| Cash Ratio | 2.69 | |||||
| Days Sales Outstanding | 2839.97 | |||||
| Days Payable | 71942.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -39.2 | |||||
| Shareholder Yield % | -31.72 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -18.72 | |||||
| Operating Margin % | -153897.86 | |||||
| Net Margin % | -176754.01 | |||||
| FCF Margin % | -55333.91 | |||||
| ROA % | -145.81 | |||||
| ROIC % | -1916.69 | |||||
| ROC (Joel Greenblatt) % | -122956.85 | |||||
| ROCE % | -177.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.8 | |||||
| EV-to-EBITDA | -2.81 | |||||
| EV-to-Revenue | 4486.35 | |||||
| EV-to-Forward-Revenue | 2044.79 | |||||
| EV-to-FCF | -8.09 | |||||
| Earnings Yield (Greenblatt) % | -35.71 | |||||
| FCF Yield % | -11.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Opthea Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.115 | ||
| EPS (TTM) (€) | -0.319 | ||
| Beta | 2.52 | ||
| Volatility % | 109.86 | ||
| 14-Day RSI | 49.13 | ||
| 14-Day ATR (€) | 0.015351 | ||
| 20-Day SMA (€) | 0.4301 | ||
| 12-1 Month Momentum % | 128.87 | ||
| 52-Week Range (€) | 0.189 - 0.555 | ||
| Shares Outstanding (Mil) | 1,231.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Opthea Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Opthea Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Opthea Ltd Frequently Asked Questions
What is Opthea Ltd(FRA:UKJ)'s stock price today?
The current price of FRA:UKJ is €0.43. The 52 week high of FRA:UKJ is €0.56 and 52 week low is €0.19.
When is next earnings date of Opthea Ltd(FRA:UKJ)?
The next earnings date of Opthea Ltd(FRA:UKJ) is 2025-02-28 Est..
Does Opthea Ltd(FRA:UKJ) pay dividends? If so, how much?
Opthea Ltd(FRA:UKJ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers